240 related articles for article (PubMed ID: 19075982)
1. Novel approaches for inhibition of mucus hypersecretion in asthma.
Agrawal A; Mabalirajan U; Ram A; Ghosh B
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):188-92. PubMed ID: 19075982
[TBL] [Abstract][Full Text] [Related]
2. Treatment of airway mucus hypersecretion.
Rogers DF; Barnes PJ
Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
[TBL] [Abstract][Full Text] [Related]
3. Niclosamide repurposed for the treatment of inflammatory airway disease.
Cabrita I; Benedetto R; Schreiber R; Kunzelmann K
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391337
[TBL] [Abstract][Full Text] [Related]
4. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
5. Current and future therapies for airway mucus hypersecretion.
Barnes PJ
Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
[TBL] [Abstract][Full Text] [Related]
6. Airway mucus hypersecretion in asthma: an undervalued pathology?
Rogers DF
Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
[TBL] [Abstract][Full Text] [Related]
7. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).
Shen Y; Huang S; Kang J; Lin J; Lai K; Sun Y; Xiao W; Yang L; Yao W; Cai S; Huang K; Wen F
Int J Chron Obstruct Pulmon Dis; 2018; 13():399-407. PubMed ID: 29430174
[TBL] [Abstract][Full Text] [Related]
8. Clinical issues of mucus accumulation in COPD.
Ramos FL; Krahnke JS; Kim V
Int J Chron Obstruct Pulmon Dis; 2014; 9():139-50. PubMed ID: 24493923
[TBL] [Abstract][Full Text] [Related]
9. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
Rogers DF
Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
[TBL] [Abstract][Full Text] [Related]
10. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.
Lai HY; Rogers DF
Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):67-76. PubMed ID: 19907312
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
12. Mucous hypersecretion and relationship to cough.
Nadel JA
Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
[TBL] [Abstract][Full Text] [Related]
13. Mucoactive drugs for asthma and COPD: any place in therapy?
Rogers DF
Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
[TBL] [Abstract][Full Text] [Related]
14. Adverse immunological imprinting by cytomegalovirus sensitizing for allergic airway disease.
Reddehase MJ
Med Microbiol Immunol; 2019 Aug; 208(3-4):469-473. PubMed ID: 31076879
[TBL] [Abstract][Full Text] [Related]
15. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
16. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma.
Lee M; Kim S; Kwon OK; Oh SR; Lee HK; Ahn K
Int Immunopharmacol; 2009 Apr; 9(4):418-24. PubMed ID: 19185061
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
Atanasova KR; Reznikov LR
Respir Res; 2018 Aug; 19(1):149. PubMed ID: 30081920
[TBL] [Abstract][Full Text] [Related]
19. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
20. Emerging mucus regulating drugs in inflammatory and allergic lung disease.
Hauber HP; Zabel P
Inflamm Allergy Drug Targets; 2008 Mar; 7(1):30-4. PubMed ID: 18473898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
